不同剂量右美托咪定对丙泊酚–芬太尼复合用于宫颈锥切术麻醉效果的影响
Influence of Different Doses of Dexmedetomidine on the Anesthesia Effect of Propofol-Fentanyl Combined in Cervical Conization
摘要: 目的:比较复合不同剂量右美托咪定在宫颈锥切术中对患者呼吸、循环及恢复时间的影响。方法:选择择期拟行宫颈锥切术的患者90例,ASA I~II级,年龄18~60岁,体重45~75 kg,BMI 18~28 kg∙m−2。按照随机数字表法将患者分为3组,每组30例。D1组、D2组和D3组分别于患者入室后静脉输注右美托咪定0.3、0.6、0.9 μg∙kg−1,泵注时间10 min。随后靶控输注丙泊酚(起始靶浓度1.5 μg∙mL−1)和静注芬太尼0.5 μg∙kg−1复合麻醉。观察并记录各时间点的心率(HR)、平均动脉压(MAP)、呼吸频率(RR)、呼吸末二氧化碳(PETCO2)、丙泊酚效应室浓度(Ce)。记录丙泊酚及芬太尼用量,苏醒时间,恢复时间,不良反应,术后调查术者及患者的满意度。结果:由于影响手术操作,D1组3例患者使用了神级肌肉阻滞剂,排除在研究之外。与D1组相比,D2组患者术中PETCO2和RR均无显著降低,呼吸维持稳定,MAP无显著降低,血流动力学稳定(P < 0.05)。与D3组相比,D2组患者HR无显著降低,血流动力学稳定(P < 0.05)。D1组舌后坠的发生率为51.9%,呼吸暂停发生率为18.5%,血压降低发生率为25.9%,D3组心动过缓发生率为73.3%,与D2组差异显著(P < 0.05)。与D1组相比,D2及D3组丙泊酚和芬太尼用量减少(P < 0.05)。三组患者苏醒时间无显著差异(P > 0.05),D2、D3组恢复时间更短(P < 0.05)。三组手术时间、患者及术者的满意度无显著差异(P > 0.05)。结论:与0.3 μg∙kg−1和0.9 μg∙kg−1的右美托咪定相比,0.6 μg∙kg−1右美托咪定减少了全麻药物的用量,提供了更稳定的呼吸和血流动力学特征,离室和恢复时间更短。
Abstract: Objective: To evaluate the effects of different doses of dexmedetomidine on respiration, circulation and recovery time during anesthesia in patients undergoing cervical conization. Methods: Ninety patients, ASA physical status I~II, aged 18~60 years, weighing 45~75 kg, BMI 18~28 kg∙m−2, undergoing cervical conization, were randomly divided into groups 0.3 μg∙kg−1 (D1), 0.6 μg∙kg−1 (D2), 0.9 μg∙kg−1 (D3) using a random number table by nurse anesthetist (not participating in observation). Blind method was used in this study. Dexmedetomidine 0.3, 0.6, 0.9 μg∙kg−1 were infused intravenously for 10 min before the patients are quiet in groups D1, D2, D3, respectively. And then TCI propofol (the target plasma concentration was set at 1.5 μg∙mL−1) and fentanyl 0.5 μg∙kg−1 were given. The assessment of HR, MAP, RR, PETCO2, Ce were continuously monitored. Dose of propofol and fentanyl, awakening time, recovery time, the incidence of adverse reaction were also recorded. Satisfaction of surgeons and patients were investigated after surgery. Results: Eighty-seven patients were enrolled, and three patients in group D1 were excluded from the study because of neuromuscular blocking agent use. PETCO2, RR, MAP were not significantly lower in group D2 than in group D1, and respiratory was stable (P < 0.05). HR was not significantly lower in group D2 than in group D3, and the patients were hemodynamically stable (P < 0.05). The rate of glossocoma, apnea and hypotension is 51.9%, 18.5%, 25.9% respectively in group D1, the rate of bradycardia is 93.3% in group D3; there was significant difference with group D2 (P < 0.05). Dose of propofol and fentanyl decreased in group D2 and D3 compared with group D1 (P < 0.05). There was no significant difference in operative time, and the satisfaction rate of both patients and operators between the three groups (P > 0.05). Conclusion: Compared with 0.3 and 0.9 μg·kg−1, dexmedetomidine, 0.6 μg·kg−1 intravenous infusion reduced dosage of general anesthetic drugs, better kept the stability of respiration and circulation, and shortened the recovery time.
文章引用:蔡胜男, 王世端, 贾媛芳, 米军桥, 李欢妮. 不同剂量右美托咪定对丙泊酚–芬太尼复合用于宫颈锥切术麻醉效果的影响[J]. 临床医学进展, 2021, 11(3): 1294-1300. https://doi.org/10.12677/ACM.2021.113185

参考文献

[1] Kunisawa, T., Ueno, M., Kurosawa, A., et al. (2011) Dexmedetomidine Can Stabilize Hemodynamics and Spare Anesthetics before Cardiopulmonary Bypass. Journal of Anesthesia, 2, 818-822. [Google Scholar] [CrossRef] [PubMed]
[2] Gregory, B., Hammer, M.D., Bridget, M., Philip, M.D., Alan, R., Schroeder, M.D., et al. (2005) Prolonged Infusion of Dexmedetomidine for Sedation Following Tracheal Resection. Pediatric Anesthesia, 15, 616-620. [Google Scholar] [CrossRef] [PubMed]
[3] Peden, C.J., Cloote, A.H., Stratford, N., et al. (2001) The Effect of Intravenous Dexmedetomidine Premedication on the Dose Requirement of Propofol to Induce Loss of Consciousness in Patients Receiving Alfentanil. Anaesthesia, 56, 408-413. [Google Scholar] [CrossRef] [PubMed]
[4] 欧阳利华, 冯芳. 用右美托咪定对接受靶控输注丙泊酚静脉麻醉的宫腔镜手术患者进行辅助麻醉的效果[J]. 当代医药论丛, 2020, 18(8): 46-47.
[5] 阎玮, 袁莉, 王世端, 江岩, 高鲜丽, 刘少艳. 右美托咪定复合丙泊酚在宫颈锥切手术麻醉中的应用[J]. 中国新药与临床杂志, 2012, 31(4): 206-209.
[6] Kakkar, A., Tyagi, A., Nabi, N., et al. (2016) Comparison of Clonidine and Dexmedetomidine for Attenuation of Laryngoscopy and Intubation Response—A Randomized Controlled Trial. Journal of Clinical Anesthesia, 33, 283-288. [Google Scholar] [CrossRef] [PubMed]
[7] Hemmings, H.C. and Hopkins, P.M. (2006) Foundations of Anaesthesia: Basic Sciences for Clinical Practice, 2nd Edition, Elsevier Mosby, 573-581.
[8] 吴迷迷, 王世端, 夏婧, 柳国强, 梁永新. 不同剂量右美托咪定对冠状动脉搭桥术患者麻醉诱导期间血流动力学的影响[J]. 临床麻醉学杂志, 2018, 34(9): 882-885.
[9] Ayse, M., Rauf, G., Ibrahim, E., et al. (2010) Premedication with Dexmedetomidine Alone or Together with 0.5% Lidocaine for IVRA. Musculoskeletal, 164, 242-247. [Google Scholar] [CrossRef] [PubMed]
[10] Weerink Maud, A.S., Struys Michel, M.R.F., Hannivoort Laura, N., et al. (2017) Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine. Clinical Pharmacokinetics, 56, 893-913. [Google Scholar] [CrossRef] [PubMed]
[11] Pekka, T., Errol, L. and Ronald, B. (2003) Systemically Administered Alpha2-Agonist-Induced Peripheral Vasoconstriction in Humans. Anesthesiology, 99, 65-70. [Google Scholar] [CrossRef] [PubMed]
[12] Takayuki, K., Osamu, N., Michio, N., et al. (2009) Dexmedetomidine Suppresses the Decrease in Blood Pressure during Anesthetic Induction and Blunts the Cardiovascular Response to Tracheal Intubation. Journal of Clinical Anesthesia, 21, 194-199.
[13] Weerink, M.A.S., Struys, M.M.R.F., Hannivoort, L.N., et al. (2017) Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine. Clinical Pharmacokinetics, 56, 893-913. [Google Scholar] [CrossRef] [PubMed]
[14] Cai, Y., Li, W. and Chen, K. (2013) Efficacy and Safety of Spontaneous Ventilation Technique Using Dexmedetomidine for Rigid Bronchoscopic Airway Foreign Body Removal in Children. Pediatric Anesthesia, 23, 1048-1053. [Google Scholar] [CrossRef] [PubMed]